{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:51:58Z","timestamp":1782906718433,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-024-03566-2","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T01:59:18Z","timestamp":1731895158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between chronic kidney disease and cardiovascular disease risk factors in elderly: results from the first phase of Fasa and Shahedieh cohort studies"],"prefix":"10.1186","volume":"25","author":[{"given":"Fatemeh","family":"Zarshenas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azizallah","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6455-0747","authenticated-orcid":false,"given":"Masoud","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"issue":"7","key":"3566_CR1","doi-asserted-by":"publisher","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill NR, Fatoba ST, Oke JL, Hirst JA, O\u2019Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease\u2013a systematic review and meta-analysis. PLoS ONE. 2016;11(7):e0158765. https:\/\/doi.org\/10.1371\/journal.pone.0158765","journal-title":"PLoS ONE"},{"issue":"6","key":"3566_CR2","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/1744-9987.12716","volume":"22","author":"S Bouya","year":"2018","unstructured":"Bouya S, Balouchi A, Rafiemanesh H, Hesaraki M. Prevalence of chronic kidney disease in Iranian general population: a meta-analysis and systematic review. Therapeutic Apheresis dialysis. 2018;22(6):594\u20139. https:\/\/doi.org\/10.1111\/1744-9987.12716","journal-title":"Therapeutic Apheresis dialysis"},{"issue":"10225","key":"3566_CR3","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/S0140-6736(19)32977-0","volume":"395","author":"P Cockwell","year":"2020","unstructured":"Cockwell P, Fisher L-A. The global burden of chronic kidney disease. Lancet. 2020;395(10225):662\u20134. https:\/\/doi.org\/10.1016\/S0140-6736(19)32977-0","journal-title":"Lancet"},{"key":"3566_CR4","doi-asserted-by":"publisher","unstructured":"Costa BSR, Freitas EPS, Cruz MS, Duarte VHR, Silva AMGd S, ICCd, et al. Association between kidney function and Framingham risk score in an admixed population of Brazil. Brazilian J Pharm Sci. 2018;53. https:\/\/doi.org\/10.1590\/s2175-97902017000317185","DOI":"10.1590\/s2175-97902017000317185"},{"issue":"2","key":"3566_CR5","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3390\/ijms21020601","volume":"21","author":"J Rysz","year":"2020","unstructured":"Rysz J, Gluba-Brz\u00f3zka A, Rysz-G\u00f3rzy\u0144ska M, Franczyk B. The role and function of HDL in patients with chronic kidney disease and the risk of cardiovascular disease. Int J Mol Sci. 2020;21(2):601. https:\/\/doi.org\/10.3390\/ijms21020601","journal-title":"Int J Mol Sci"},{"key":"3566_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11255-019-02349-1","volume":"52","author":"J Jagie\u0142a","year":"2020","unstructured":"Jagie\u0142a J, Bartnicki P, Rysz J. Selected cardiovascular risk factors in early stages of chronic kidney disease. Int Urol Nephrol. 2020;52:303\u201314. https:\/\/doi.org\/10.1007\/s11255-019-02349-1","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"3566_CR7","doi-asserted-by":"publisher","first-page":"e0192895","DOI":"10.1371\/journal.pone.0192895","volume":"13","author":"RW Major","year":"2018","unstructured":"Major RW, Cheng MR, Grant RA, Shantikumar S, Xu G, Oozeerally I, et al. Cardiovascular disease risk factors in chronic kidney disease: a systematic review and meta-analysis. PLoS ONE. 2018;13(3):e0192895. https:\/\/doi.org\/10.1371\/journal.pone.0192895","journal-title":"PLoS ONE"},{"issue":"3","key":"3566_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000494116","volume":"9","author":"P Wu","year":"2019","unstructured":"Wu P, Luo F, Fang Z. Multivessel coronary revascularization strategies in patients with chronic kidney disease: a meta-analysis. Cardiorenal Med. 2019;9(3):145\u201359. https:\/\/doi.org\/10.1159\/000494116","journal-title":"Cardiorenal Med"},{"key":"3566_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijcard.2017.05.022","volume":"243","author":"C Engelbertz","year":"2017","unstructured":"Engelbertz C, Reinecke H, Breithardt G, Schmieder RE, Fobker M, Fischer D, et al. Two-year outcome and risk factors for mortality in patients with coronary artery disease and renal failure: the prospective, observational CAD-REF registry. Int J Cardiol. 2017;243:65\u201372. https:\/\/doi.org\/10.1016\/j.ijcard.2017.05.022","journal-title":"Int J Cardiol"},{"issue":"2","key":"3566_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.artere.2023.03.002","volume":"35","author":"A Ruiz-Garcia","year":"2023","unstructured":"Ruiz-Garcia A, Arranz-Mart\u00ednez E, Iturmendi-Mart\u00ednez N, Fern\u00e1ndez-Vicente T, Rivera-Teijido M, Garc\u00eda-\u00c1lvarez JC. Prevalence rates of chronic kidney disease and its association with cardiometabolic factors and cardiovascular diseases. SIMETAP-CKD study. Cl\u00ednica E Investigaci\u00f3n en Arteriosclerosis. (English Edition). 2023;35(2):64\u201374. https:\/\/doi.org\/10.1016\/j.artere.2023.03.002","journal-title":"(English Edition)"},{"issue":"9","key":"3566_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/nep.12493","volume":"20","author":"S Iimori","year":"2015","unstructured":"Iimori S, Naito S, Noda Y, Nishida H, Kihira H, Yui N, et al. Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in J apan: the CKD-ROUTE study. Nephrology. 2015;20(9):601\u20138. https:\/\/doi.org\/10.1111\/nep.12493","journal-title":"Nephrology"},{"issue":"2","key":"3566_CR12","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1053\/j.ajkd.2015.01.021","volume":"66","author":"R Shah","year":"2015","unstructured":"Shah R, Matthews GJ, Shah RY, McLaughlin C, Chen J, Wolman M, et al. Serum fractalkine (CX3CL1) and cardiovascular outcomes and diabetes: findings from the chronic renal insufficiency cohort (CRIC) study. Am J Kidney Dis. 2015;66(2):266\u201373. https:\/\/doi.org\/10.1053\/j.ajkd.2015.01.021","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"3566_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-023-03056-x","volume":"24","author":"JD Kampmann","year":"2023","unstructured":"Kampmann JD, Heaf JG, Mogensen CB, Mickley H, Wolff DL, Brandt F. Prevalence and incidence of chronic kidney disease stage 3\u20135\u2013results from KidDiCo. BMC Nephrol. 2023;24(1):1\u20139. https:\/\/doi.org\/10.1186\/s12882-023-03056-x","journal-title":"BMC Nephrol"},{"issue":"6","key":"3566_CR14","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.3390\/diagnostics13061146","volume":"13","author":"F Samaan","year":"2023","unstructured":"Samaan F, Damiani BB, Kirsztajn GM, Sesso R. A cross-sectional study on the prevalence and risk stratification of chronic kidney disease in cardiological patients in S\u00e3o Paulo, Brazil. Diagnostics. 2023;13(6):1146. https:\/\/doi.org\/10.3390\/diagnostics13061146","journal-title":"Diagnostics"},{"issue":"1","key":"3566_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-017-0441-9","volume":"18","author":"J Yuan","year":"2017","unstructured":"Yuan J, Zou X-R, Han S-P, Cheng H, Wang L, Wang J-W, et al. Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE). BMC Nephrol. 2017;18(1):1\u201312. https:\/\/doi.org\/10.1186\/s12882-017-0441-9","journal-title":"BMC Nephrol"},{"key":"3566_CR16","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s11255-019-02157-7","volume":"51","author":"S Chen","year":"2019","unstructured":"Chen S, Hsu W-y, Lin Y-N, Wang C-Y, Wu C-H, Chang K-H. Incidence and risk of major adverse cardiovascular events in middle-aged patients with chronic kidney disease: a population-based cohort study. Int Urol Nephrol. 2019;51:1219\u201327. https:\/\/doi.org\/10.1007\/s11255-019-02157-7","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"3566_CR17","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1001\/jamacardio.2016.4652","volume":"2","author":"N Bansal","year":"2017","unstructured":"Bansal N, Katz R, Robinson-Cohen C, Odden MC, Dalrymple L, Shlipak MG, et al. Absolute rates of heart failure, coronary heart disease, and stroke in chronic kidney disease: an analysis of 3 community-based cohort studies. JAMA Cardiol. 2017;2(3):314\u20138. https:\/\/doi.org\/10.1001\/jamacardio.2016.4652","journal-title":"JAMA Cardiol"},{"issue":"1","key":"3566_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.23876\/j.krcp.18.0118","volume":"38","author":"C Lee","year":"2019","unstructured":"Lee C, Yun H-R, Joo YS, Lee S, Kim J, Nam KH, et al. Framingham risk score and risk of incident chronic kidney disease: a community-based prospective cohort study. Kidney Res Clin Pract. 2019;38(1):49. https:\/\/doi.org\/10.23876\/j.krcp.18.0118","journal-title":"Kidney Res Clin Pract"},{"issue":"4\u20135","key":"3566_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000430868","volume":"41","author":"MC Foster","year":"2015","unstructured":"Foster MC, Hwang S-J, Massaro JM, Jacques PF, Fox CS, Chu AY. Lifestyle factors and indices of kidney function in the Framingham heart study. Am J Nephrol. 2015;41(4\u20135):267\u201374. https:\/\/doi.org\/10.1159\/000430868","journal-title":"Am J Nephrol"},{"issue":"4","key":"3566_CR20","doi-asserted-by":"publisher","first-page":"e13945","DOI":"10.1111\/eci.13945","volume":"53","author":"SM Fanaei","year":"2023","unstructured":"Fanaei SM, Mehran L, Amouzegar A, Masoumi S, Amouzegar A, Azizi F. The impact of metabolic syndrome on chronic kidney disease development. Insights from a big prospective study. Eur J Clin Invest. 2023;53(4):e13945. https:\/\/doi.org\/10.1111\/eci.13945","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"3566_CR21","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/fsn3.3197","volume":"11","author":"S Fereidouni","year":"2023","unstructured":"Fereidouni S, Hejazi N, Homayounfar R, Farjam M. Diet quality and dietary acid load in relation to cardiovascular disease mortality: results from Fasa PERSIAN cohort study. Food Sci Nutr. 2023;11(3):1563\u201371. https:\/\/doi.org\/10.1002\/fsn3.3197","journal-title":"Food Sci Nutr"},{"issue":"5","key":"3566_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2217\/cpr.14.46","volume":"11","author":"M Mallappallil","year":"2014","unstructured":"Mallappallil M, Friedman EA, Delano BG, McFarlane SI, Salifu MO. Chronic kidney disease in the elderly: evaluation and management. Clin Pract (London England). 2014;11(5):525. https:\/\/doi.org\/10.2217\/cpr.14.46","journal-title":"Clin Pract (London England)"},{"issue":"1","key":"3566_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/jcm9010004","volume":"9","author":"E Vidal-Petiot","year":"2019","unstructured":"Vidal-Petiot E, Greenlaw N, Kalra PR, Garcia-Moll X, Tardif J-C, Ford I, et al. Chronic kidney disease has a graded association with death and cardiovascular outcomes in stable coronary artery disease: an analysis of 21,911 patients from the CLARIFY registry. J Clin Med. 2019;9(1):4. https:\/\/doi.org\/10.3390\/jcm9010004","journal-title":"J Clin Med"},{"issue":"12","key":"3566_CR24","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1681\/ASN.2020040476","volume":"31","author":"PF Orlandi","year":"2020","unstructured":"Orlandi PF, Xie D, Yang W, Cohen JB, Deo R, Ricardo AC, et al. Slope of kidney function and its association with longitudinal mortality and cardiovascular disease among individuals with CKD. J Am Soc Nephrology: JASN. 2020;31(12):2912. https:\/\/doi.org\/10.1681\/ASN.2020040476","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"3","key":"3566_CR25","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1093\/ije\/dyac241","volume":"52","author":"R Homayounfar","year":"2023","unstructured":"Homayounfar R, Farjam M, Bahramali E, Sharafi M, Poustchi H, Malekzadeh R, et al. Cohort profile: the Fasa adults cohort study (FACS): a prospective study of non-communicable diseases risks. Int J Epidemiol. 2023;52(3):e172\u20138. https:\/\/doi.org\/10.1093\/ije\/dyac241","journal-title":"Int J Epidemiol"},{"issue":"4","key":"3566_CR26","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/aje\/kwx314","volume":"187","author":"H Poustchi","year":"2018","unstructured":"Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar A-A, Hekmatdoost A, et al. Prospective epidemiological research studies in Iran (the PERSIAN cohort study): rationale, objectives, and design. Am J Epidemiol. 2018;187(4):647\u201355. https:\/\/doi.org\/10.1093\/aje\/kwx314","journal-title":"Am J Epidemiol"},{"issue":"11","key":"3566_CR27","first-page":"691","volume":"20","author":"S Eghtesad","year":"2017","unstructured":"Eghtesad S, Mohammadi Z, Shayanrad A, Faramarzi E, Joukar F, Hamzeh B, et al. The PERSIAN cohort: providing the evidence needed for healthcare reform. Arch Iran Med. 2017;20(11):691\u20135.","journal-title":"Arch Iran Med"},{"issue":"1","key":"3566_CR28","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.34172\/jrip.2022.01","volume":"11","author":"M Mirzaei","year":"2021","unstructured":"Mirzaei M, Nourimajalan N, Morovati H, Askarishahi M, Hemayati R. Prevalence and predisposing factors of chronic kidney disease in Yazd city; a population-based study. J Ren Injury Prev. 2021;11(1):e1\u2013e. https:\/\/doi.org\/10.34172\/jrip.2022.01","journal-title":"J Ren Injury Prev"},{"issue":"6","key":"3566_CR29","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1159\/000518812","volume":"30","author":"DS Chakraborty","year":"2021","unstructured":"Chakraborty DS, Lahiry S, Choudhury S. Hypertension clinical practice guidelines (ISH, 2020): what is new? Med Principles Pract. 2021;30(6):579\u201384. https:\/\/doi.org\/10.1159\/000518812","journal-title":"Med Principles Pract"},{"key":"3566_CR30","doi-asserted-by":"crossref","unstructured":"Khajehdehi P, Malekmakan L, Pakfetrat M, Roozbeh J, Sayadi M. Prevalence of chronic kidney disease and its contributing risk factors in southern Iran a cross-sectional adult population-based study. 2014.","DOI":"10.5402\/2013\/427230"},{"issue":"1","key":"3566_CR31","first-page":"52","volume":"31","author":"B Ghiasi","year":"2023","unstructured":"Ghiasi B, Nazari H, Babarabiei MA, Raiesifar A. Prevalence and causes of chronic kidney disease in patients referred to the nephrology clinic in Ilam. J Ilam Univ Med Sci. 2023;31(1):52\u20139.","journal-title":"J Ilam Univ Med Sci"},{"issue":"1","key":"3566_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-020-01745-5","volume":"21","author":"LE Zijlstra","year":"2020","unstructured":"Zijlstra LE, Trompet S, Mooijaart SP, van Buren M, Sattar N, Stott DJ, et al. The association of kidney function and cognitive decline in older patients at risk of cardiovascular disease: a longitudinal data analysis. BMC Nephrol. 2020;21(1):1\u201310. https:\/\/doi.org\/10.1186\/s12882-020-01745-5","journal-title":"BMC Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03566-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03566-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03566-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:30:28Z","timestamp":1782905428000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-024-03566-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3566"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03566-2","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"12 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Article updated to correct the author\u2019s affiliation.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the ethics committee in biomedical research of Shahid Sadoughi University of Medical Sciences (IRAN). (Code of ethics: IR.SSU.SPH.REC.1401.051). It should be noted that written informed consent was obtained from all the participants in the first stage of the study of Fasa and Shahedieh cohort studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"413"}}